Hung, Man-Hsin <br/><br/>
SET antagonist enhances the chemosensitivity of non-small cell lung cancer cells by reactivating protein phosphatase 2A.  [electronic resource] 

 -  Oncotarget  Jan 2016 
 - 638-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.6313  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>DNA-Binding Proteins<br/>Disease-Free Survival<br/>Drug Synergism<br/>Enzyme Activation--drug effects<br/>Female<br/>Histone Chaperones--antagonists & inhibitors<br/>Humans<br/>Immunohistochemistry<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mice, Nude<br/>Middle Aged<br/>Paclitaxel--administration & dosage<br/>Protein Phosphatase 2--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Quinazolines--administration & dosage<br/>RNA Interference<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Transcription Factors--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays